Home › NDC Lookup › Ingredients › Tioconazole › 70677-1224-01
🧴image loading
(from DailyMed)

foster and thrive tioconazole 6.5 g/100g Ointment, 1 applicator — NDC 70677-1224-1 (Billing 70677-1224-01)

by Strategic Sourcing Services LLC · 1 APPLICATOR in 1 CARTON / 4.6 g in 1 APPLICATOR

This is a package of 1 applicator of foster and thrive tioconazole 6.5 g/100g Ointment from Strategic Sourcing Services LLC, marketed since Oct 2023 and currently FDA-listed; retail pharmacies pay about $2.41 per g (NADAC). It is this product's only package size.

NDC 70677-1224-01
🏷️ FDA NDC (as labeled) 70677-1224-1 billing pads the package segment with a zero
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70677-1224-1
Product NDC 70677-1224
11-digit billing NDC 70677122401
NCPDP billing unit GM — per gram (weight)
RxCUI 198380
UNII S57Y5X1117
Application # ANDA075915
SPL Set ID daa1027d-de49-41dc-9d4d-9bbdd7b359c8
Established class (EPC) Azole Antifungal
Chemical class Azoles
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-10-25
Route VAGINAL
Dosage form OINTMENT
Substance TIOCONAZOLE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 55104075004220
GCN Seq No 012092
GCN 05280
HICL code 004569
Ingredient (HICL) Tioconazole
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q4
Therapeutic class — intermediate (HIC2) Vaginal Preparations
HIC3 code Q4F
Therapeutic class — specific (HIC3) Vaginal Antifungals
AHFS code 84:04.08.08
AHFS class Azoles (Skin And Mucous Membrane)
FDB label name FT TIOCONAZOLE-1 6.5% OINTMENT
FDB brand name Tioconazole-1
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 012092
  • GCN: 05280
  • GPI-14 (Medi-Span): 55104075004220
  • HICL (First Databank): 004569
  • AHFS class code: 84:04.08.08
  • RxCUI (RxNorm): 198380
Why two NDCs? The FDA registers this code as 70677-1224-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1224-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Azole Antifungal class.

Pharmacologic class Azole Antifungal
Drug family (ATC) Imidazole and triazole derivatives, Imidazole derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FT TIOCONAZOLE-1 6.5% OINTMENT Ingredient Tioconazole
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $2.409 $11.08 / 4.6 g
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $2.434 $2.356
Flat over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70677-1224-01 You're viewing this Main listing 1 APPLICATOR in 1 CARTON / 4.6 g in 1 APPLICATOR 2023-10-25 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
good sense tioconazole 1 6.5 g/100g 00113-0426-54 L. 1 pouch $2.409 — Availability likely —
Leader Tioconazole 1 6.5 g/100g 70000-0357-01 Cardinal 1 applicator $2.409 — Availability likely —
foster and thrive tioconazole 6.5 g/100gthis 70677-1224-01 Strategic 1 applicator $2.409 — Availability likely —
Tioconazole 1 6.5 g/100g 00363-0426-54 Walgreen 1 pouch — — FDA listed —
Vagistat 6.5 g/100g 11509-0426-01 Combe 1 pouch — — FDA listed —
Up and up tioconazole 1 6.5 g/100g 11673-0426-54 Target 1 pouch — — FDA listed —
signature care tioconazole 1 6.5 g/100g 21130-0060-54 Safeway 1 pouch — — FDA listed —
Tioconazole 1 6.5 g/100g 21130-0781-54 Safeway 1 pouch — — FDA listed —
Topcare Tioconazole 1 6.5 g/100g 36800-0426-54 Topco 1 pouch — — FDA listed —
Tioconazole 1 6.5 g/100g 37808-0426-54 H 1 pouch — — FDA listed —
Equaline Tioconazole 1 6.5 g/100g 41163-0032-54 United 1 pouch — — FDA listed —
tioconazole 1 6.5 g/100g 41250-0426-54 Meijer 1 pouch — — FDA listed —
CareOne Tioconazole 1 6.5 g/100g 41520-0426-54 American 1 pouch — — FDA listed —
Equate tioconazole 1 day 6.5 g/100g 49035-0426-54 Wal-Mart 1 pouch — — FDA listed —
dg health tioconazole 1 6.5 g/100g 55910-0731-54 Dolgencorp 1 pouch — — FDA listed —
tioconazole 1 6.5 g/100g 59779-0718-26 CVS 1 pouch — — FDA listed —
Monistat Tioconazole 1 6.5 g/100g 63736-0413-01 Insight 1 applicator — — FDA listed —
basic care tioconazole 6.5 g/100g 72288-0426-54 Amazon.com 1 pouch — — FDA listed —
Tioconazole 1 6.5 g/100g 72288-0222-54 Amazon.com 1 pouch — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Oct 2023
📍
2026
Currently FDA-listed
3 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerStrategic Sourcing Services LLC
Application holderL PERRIGO CO
FDA applicationANDA075915 (ANDA)
Labeler code70677
First marketedOct 2023
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 6 words ▾

Use • treats vaginal yeast infections

⏱️ Dosage and Administration 68 words ▾

Directions • before using this product, read the enclosed brochure and instructions on printed packet for complete directions and information • adults and children 12 years of age and over: • open the printed packet just before use and remove purple cap • insert entire contents of applicator into the vagina at bedtime. Throw applicator away after use. • children under 12 years of age: ask a doctor

⚠️ Warnings ~1 min read ▾

Warnings For vaginal use only Do not use if you have never had a vaginal yeast infection diagnosed by a doctor Ask a doctor before use if you have • vaginal itching and discomfort for the first time • lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting or foul-smelling vaginal discharge. You may have a more serious condition. • vaginal yeast infections often (such as once a month or 3 in 6 months). You could be pregnant or have a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system. • been exposed to the human immunodeficiency virus (HIV) that causes AIDS When using this product • do not use tampons, douches, spermicides, or other vaginal products.

Condoms and diaphragms may be damaged and fail to prevent pregnancy or sexually transmitted disease (STDs). • do not have vaginal intercourse • mild increase in vaginal burning, itching or irritation may occur • if you do not get complete relief ask a doctor before using another product Stop use and ask a doctor if • symptoms do not get better after 3 days • symptoms last more than 7 days • you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📦 Storage and Handling 76 words ▾

Other information • this product is a 1-dose treatment. Most women do not experience complete relief of their symptoms in just one day. Most women experience some relief within one day and complete relief of symptoms within 7 days. • if you have questions about vaginal yeast infections, consult your doctor • store at 20 ° -25 ° C (68 ° -77 ° F) • see end flap of carton for lot number and expiration date

🧪 Active Ingredient 9 words ▾

Active ingredient (in each applicator) Tioconazole 300 mg (6.5%)

🧪 Inactive Ingredients 9 words ▾

Inactive ingredients butylated hydroxyanisole, magnesium aluminum silicate, white petrolatum

🎯 Purpose 3 words ▾

Purpose Vaginal antifungal

📄 Do Not Use 16 words ▾

Do not use if you have never had a vaginal yeast infection diagnosed by a doctor

📄 Ask a Doctor Before Use If 87 words ▾

Ask a doctor before use if you have • vaginal itching and discomfort for the first time • lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting or foul-smelling vaginal discharge. You may have a more serious condition. • vaginal yeast infections often (such as once a month or 3 in 6 months). You could be pregnant or have a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system. • been exposed to the human immunodeficiency virus (HIV) that causes AIDS

📄 When Using This Product 63 words ▾

When using this product • do not use tampons, douches, spermicides, or other vaginal products. Condoms and diaphragms may be damaged and fail to prevent pregnancy or sexually transmitted disease (STDs). • do not have vaginal intercourse • mild increase in vaginal burning, itching or irritation may occur • if you do not get complete relief ask a doctor before using another product

📄 Stop Use and Ask a Doctor If 40 words ▾

Stop use and ask a doctor if • symptoms do not get better after 3 days • symptoms last more than 7 days • you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 20 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📄 Questions or Comments 12 words ▾

Questions or comments? Call 833-358-6431 Monday to Friday 9:00am to 7:00pm EST

📄 Package Label / Principal Display Panel 69 words ▾

Principal Display Panel Foster & Thrive ™ Tioconazole-1 Tioconazole Ointment, 6.5% VAGINAL ANTIFUNGAL 1-Dose Treatment | Vaginal Ointment 1-Dose Treatment with 1 Pre-Filled Ointment Applicator Educational Brochure Enclosed COMPARE TO MONISTAT ® 1 ACTIVE INGREDIENT Foster & Thrive ™ Tioconazole-1 Tioconazole Ointment, 6.5% VAGINAL ANTIFUNGAL Odorless Formula | 1 Pre-Filled Ointment Applicator Cures Most Vaginal Yeast Infections 1-Dose Treatment NET WT 4.6 g (0.16 OZ) PRE-FILLED APPLICATOR 426-km-tioconazole-1-1 426-km-tioconazole-1-2

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for foster and thrive tioconazole (this brand).

Top reported reactions

Vulvovaginal Burning Sensation518
Vulvovaginal Swelling290
Condition Aggravated225
Vulvovaginal Pain224
Vulvovaginal Pruritus195
Vulvovaginal Discomfort160
Vaginal Discharge59

Age at onset

Adult49
Elderly6

Reporter sex

1,512 reports
Male · 2%
Female · 98%
Unknown · 0%

Serious outcomes

Hospitalization39
Life-threatening2
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 299 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Strategic Sourcing Services LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Strategic Sourcing Services LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 70677-1223-01 · Strategic 70677-1225-01 · Strategic →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.